These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30593524)

  • 21. Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells.
    Salvatori L; Caporuscio F; Coroniti G; Starace G; Frati L; Russo MA; Petrangeli E
    J Cell Physiol; 2009 Jul; 220(1):35-44. PubMed ID: 19347870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The tetraspanin CD81 mediates the growth and metastases of human osteosarcoma.
    Mizoshiri N; Shirai T; Terauchi R; Tsuchida S; Mori Y; Hayashi D; Kishida T; Arai Y; Mazda O; Nakanishi T; Kubo T
    Cell Oncol (Dordr); 2019 Dec; 42(6):861-871. PubMed ID: 31494861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT-receptor complex.
    Zhao SJ; Jiang YQ; Xu NW; Li Q; Zhang Q; Wang SY; Li J; Wang YH; Zhang YL; Jiang SH; Wang YJ; Huang YJ; Zhang XX; Tian GA; Zhang CC; Lv YY; Dai M; Liu F; Zhang R; Zhou D; Zhang ZG
    Oncogene; 2018 Feb; 37(8):1049-1061. PubMed ID: 29084211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decitabine Response in Breast Cancer Requires Efficient Drug Processing and Is Not Limited by Multidrug Resistance.
    Dahn ML; Cruickshank BM; Jackson AJ; Dean C; Holloway RW; Hall SR; Coyle KM; Maillet H; Waisman DM; Goralski KB; Giacomantonio CA; Weaver ICG; Marcato P
    Mol Cancer Ther; 2020 May; 19(5):1110-1122. PubMed ID: 32156786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of dynamin-related protein 1 - dependent mitochondria fragmentation and suppression of osteosarcoma by cryptotanshinone.
    Yen JH; Huang HS; Chuang CJ; Huang ST
    J Exp Clin Cancer Res; 2019 Jan; 38(1):42. PubMed ID: 30691497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-derived osteosarcoma cells are resistant to methotrexate.
    Dos Santos Cavalcanti A; Meohas W; Ribeiro GO; de Sá Lopes AC; Gholamin S; Razavi M; Hanae Kasai Brunswick T; Avan A; Matheus Guimarães JA; Leite Duarte ME; Kahn SA
    PLoS One; 2017; 12(9):e0184891. PubMed ID: 28934267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
    Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
    Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decitabine-Mediated Epigenetic Reprograming Enhances Anti-leukemia Efficacy of CD123-Targeted Chimeric Antigen Receptor T-Cells.
    You L; Han Q; Zhu L; Zhu Y; Bao C; Yang C; Lei W; Qian W
    Front Immunol; 2020; 11():1787. PubMed ID: 32973749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of estrogen receptors alfa and beta mRNA and alkaline phosphatase in the differentiation of osteoblasts from elderly postmenopausal women: comparison with osteoblasts from osteosarcoma cell lines.
    Chen FP; Hsu T; Hu CH; Wang WD; Wang KC; Teng LF
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):307-12. PubMed ID: 17175487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.
    Thaler S; Schmidt M; Schad A; Sleeman JP
    Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gelsolin promotes cell growth and invasion through the upregulation of p-AKT and p-P38 pathway in osteosarcoma.
    Ma X; Sun W; Shen J; Hua Y; Yin F; Sun M; Cai Z
    Tumour Biol; 2016 Jun; 37(6):7165-74. PubMed ID: 26662962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
    Fujiwara T; Yakoub MA; Chandler A; Christ AB; Yang G; Ouerfelli O; Rajasekhar VK; Yoshida A; Kondo H; Hata T; Tazawa H; Dogan Y; Moore MAS; Fujiwara T; Ozaki T; Purdue E; Healey JH
    Mol Cancer Ther; 2021 Aug; 20(8):1388-1399. PubMed ID: 34088832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulforaphene inhibits the progression of osteosarcoma via regulating FSTL1/NF-κB pathway.
    Zhang G; Jin C; Zhu Y; Fu F; Wang G; Li S
    Life Sci; 2020 Dec; 263():118485. PubMed ID: 33017573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
    Buocikova V; Longhin EM; Pilalis E; Mastrokalou C; Miklikova S; Cihova M; Poturnayova A; Mackova K; Babelova A; Trnkova L; El Yamani N; Zheng C; Rios-Mondragon I; Labudova M; Csaderova L; Kuracinova KM; Makovicky P; Kucerova L; Matuskova M; Cimpan MR; Dusinska M; Babal P; Chatziioannou A; Gabelova A; Rundén-Pran E; Smolkova B
    Biomed Pharmacother; 2022 Mar; 147():112662. PubMed ID: 35091237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel HSP90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines.
    McCleese JK; Bear MD; Fossey SL; Mihalek RM; Foley KP; Ying W; Barsoum J; London CA
    Int J Cancer; 2009 Dec; 125(12):2792-801. PubMed ID: 19544563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Licochalcone A-Induced Apoptosis Through the Activation of p38MAPK Pathway Mediated Mitochondrial Pathways of Apoptosis in Human Osteosarcoma Cells In Vitro and In Vivo.
    Lin RC; Yang SF; Chiou HL; Hsieh SC; Wen SH; Lu KH; Hsieh YH
    Cells; 2019 Nov; 8(11):. PubMed ID: 31739642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S-adenosylmethionine in combination with decitabine shows enhanced anti-cancer effects in repressing breast cancer growth and metastasis.
    Mahmood N; Arakelian A; Cheishvili D; Szyf M; Rabbani SA
    J Cell Mol Med; 2020 Sep; 24(18):10322-10337. PubMed ID: 32720467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy.
    Manara MC; Valente S; Cristalli C; Nicoletti G; Landuzzi L; Zwergel C; Mazzone R; Stazi G; Arimondo PB; Pasello M; Guerzoni C; Picci P; Nanni P; Lollini PL; Mai A; Scotlandi K
    Mol Cancer Ther; 2018 Sep; 17(9):1881-1892. PubMed ID: 29959201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anti-tumour activity of DNA methylation inhibitor 5-aza-2'-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress.
    Gleneadie HJ; Baker AH; Batis N; Bryant J; Jiang Y; Clokie SJH; Mehanna H; Garcia P; Gendoo DMA; Roberts S; Burley M; Molinolo AA; Gutkind JS; Scheven BA; Cooper PR; Parish JL; Khanim FL; Wiench M
    Cancer Lett; 2021 Mar; 501():172-186. PubMed ID: 33359448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.